EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption

Ming-Liang Zhang, Wei-Xia Li, Xiao-Yan Wang, Ya-Li Wu, Xiao-Fei Chen, Hui Zhang, Liu-Qing Yang, Cheng-Zhao Wu, Shu-Qi Zhang, Yu-Long Chen, Ke-Ran Feng, Bin Wang und 3 weitere

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2022.1095053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Ming-Liang Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Gastrointestinal Microbiome, Multiple Sclerosis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Increasing evidence suggests that gut dysbiosis can directly or indirectly affect the immune system through the brain-gut axis and play a role in the occurrence and development of Multiple sclerosis (MS). Oxymatrine (OMAT) has been shown to ameliorate the symptoms of MS in the classical experimental autoimmune encephalomyelitis (EAE) model of MS, but whether its therapeutic role is through the correction of gut dysbiosis, is unclear.

Methods

The effects of OMAT on intestinal flora and short-chain fatty acids in EAE model mice were evaluated by 16S rRNA sequencing and GC-MS/MS, respectively, and the function change of the blood-brain barrier and intestinal epithelial barrier was further tested by immunohistochemical staining, Evans Blue leakage detection, and RT-qPCR.

Results

The alpha and beta diversity in the feces of EAE mice were significantly different from that of the control group but recovered substantially after OMAT treatment. Besides, the OMAT treatment significantly affected the gut functional profiling and the abundance of genes associated with energy metabolism, amino acid metabolism, the immune system, infectious diseases, and the nervous system. OMAT also decreased the levels of isobutyric acid and isovaleric acid in EAE mice, which are significantly related to the abundance of certain gut microbes and were consistent with the reduced expression of TNF-a, IL-6, and IL-1b. Furthermore, OMAT treatment significantly increased the expression of ZO-1 and occludin in the brains and colons of EAE mice and decreased blood-brain barrier permeability.

Conclusion

OMAT may alleviate the clinical and pathological symptoms of MS by correcting dysbiosis, restoring gut ecological and functional microenvironment, and inhibiting immune cell-mediated inflammation to remodel the brain-gut axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalGastrointestinal MicrobiomeMultiple SclerosisAnimalsMiceBlood-Brain BarrierDysbiosisRNA, Ribosomal, 16STandem Mass SpectrometrySulfadiazineHomeostasisMice, Inbred C57BLMatrines

Stichwörter der Autor:innen

brain-gut axisexperimental autoimmune encephalomyelitisgut microbiotaoxymatrineshort-chain fatty acids

Substanzen

RNA, Ribosomal, 16SSulfadiazineoxymatrineMatrines

Autor:innen und Institutionen

  • Department of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
  • Henan Province Engineering Research Center of Clinical Application, Evaluation and Transformation of Traditional Chinese Medicine, Henan Provincial Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine, Z…
  • Chengdu University of Chinese Medicine, Chengdu, China.
  • School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, M. L., Li, W. X., Wang, X. Y., Wu, Y. L., Chen, X. F., Zhang, H., Yang, L. Q., Wu, C. Z., Zhang, S. Q., Chen, Y. L., Feng, K. R., Wang, B., Niu, L., Kong, D. X., & Tang, J. F. (2023). Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2022.1095053

Vancouver

Zhang ML, Li WX, Wang XY, Wu YL, Chen XF, Zhang H, et al. Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2022.1095053

BibTeX
@article{Zhang2023,
  author = {Zhang, Ming-Liang and Li, Wei-Xia and Wang, Xiao-Yan and Wu, Ya-Li and Chen, Xiao-Fei and Zhang, Hui and Yang, Liu-Qing and Wu, Cheng-Zhao and Zhang, Shu-Qi and Chen, Yu-Long and Feng, Ke-Ran and Wang, Bin and Niu, Lu and Kong, De-Xin and Tang, Jin-Fa},
  title = {Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2022.1095053}
}
Kostenlos starten →